Tx360

· Tian Medical Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tx360, covering 2024-01-05 to 2024-01-05. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine [Phase 3]

See pricing